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Abstract: Cyclic oligochalcogenides are emerging as powerful tools 
to penetrate cells.  With disulfide ring tension maximized, selenium 
chemistry had to be explored next to enhance speed and selectivity 
of dynamic covalent exchange on the way into the cytosol.  We show 
that diseleno lipoic acid (DiSeL) delivers a variety of relevant 
substrates.  DiSeL-driven uptake of artificial metalloenzymes enables 
bioorthogonal fluorophore uncaging within cells.  Binding of a bicyclic 
peptide, phalloidin, to actin fibers evinces targeted delivery to the 
cytosol.  Automated tracking of diffusive compared to directed motility 
and immobility localizes 79% of protein-coated quantum dots (QDs) 
in the cytosol, with little endosomal capture (0.06%).  These results 
suggest that diselenolanes might act as molecular walkers along 
disulfide tracks in locally denatured membrane proteins, surrounded 
by adaptive micellar membrane defects.  Miniscule and versatile, 
DiSeL tags are also readily available, stable, soluble, and non-toxic. 
We first experienced the power of thiol-mediated uptake[1,2] when 
we replaced the peptide backbone of cell-penetrating peptides 
(CPPs)[3] with disulfide bonds in cell-penetrating poly(disulfide)s 
(CPDs).[4]  Their efficient entry into cells[5-7] was shown to occur 
through dynamic covalent disulfide exchange[8] with exofacial 
thiols on the cell surface.[4,7]  This called for the application of ring 
tension, increasing from disulfide 1 to 5 (Figure 1A).[9-11]  In 
relaxed disulfides such as 1, the CSSC dihedral angle is 90º to 
minimize the lone pair repulsion and maximize hyperconjugation 
(Figure 1B).[12]  Maximal ring tension in ETPs 5 with a CSSC ~0º 
resulted in maximal uptake activity among disulfides containing 
compounds.[10]  To enhance the activity of cyclic 
oligochalcogenides (COCs) further, replacement of sulfur by 
selenium appeared most promising. Owing to the higher 
polarizability of selenium atoms, thiolate-diselenide exchange 
reactions are known to proceed faster than with disulfides.[2,13]  
Indeed, already relaxed diselenides 6 were more potent 
transporters than disulfides 5 at maximal tension, and uptake 
efficiency further increased with tension in diselenolipoic acid 
(DiSeL) 7.[11]  Although the CXXC dihedral angle of diselenolane 
7 is smaller than that of lipoic acid 3 (~35º), its ring tension is lower 
because the Se bonds are longer.[11]  Diselenide-mediated uptake 
nevertheless exceeds disulfide-mediated uptake because the 
higher polarizability increases exchange rates and selectivity, 
resulting in pronounced selenophilicity.[2,13] 
Figure 1.  (A) Flow cytometry trends for uptake of fluorescein-labeled 
dichalcogenides 1-7 into HeLa Kyoto cells,[8-10] with (B) selected CXXC dihedral 
angles (X = S or Se). 
Uptake with acyclic diselenides 6 (and dithiolanes 3 and 4) suffers 
from endosomal capture probably because fast exchange with 
cell surface thiols results in stable selenosulfides.[11]  With DiSeL 
7 (and ETPs 5), after reacting with cellular thiols, the proximal 
selenolates (and thiolates) remain deprotonated and thus reactive, 
assuring that the transporters can move on and hop along 
disulfides and thiols to avoid endosomal capture and enter into 
cytosol and nucleus.[11]  DiSeL-mediated uptake has been shown 
to be insensitive to common endocytosis inhibitors and non-toxic 
up to at least 100 µM.[11]  These results on COC-mediated cellular 
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uptake have been obtained with fluorescein-labeled 
dichalcogenides 1-7 (Figure 1A).  Preliminary results on 
biologically more relevant substrates are available only for AspA 
4, which is weakly active and suffers from endosomal capture.[14]  
Based on the unique characteristics found for diselenolanes,[11] 
the objective of this study was to explore the compatibility of 
DiSeL-mediated uptake with larger substrates of biological 
relevance.  Using mostly topics that have been developed 
recently to characterize the large CPD polymers,[5,6] we here 
report that cellular uptake of the tiny diselenolanes is compatible 
with the cytosolic delivery of a broad variety of functional 
substrates with diameters up to 15 nm.  The combination of this 
broad substrate tolerance with insights from model studies call for 
a mode of action that envisions DiSeL as molecular walkers[15] 
that move along disulfide tracks in transmembrane proteins, 
causing temporary local denaturation[16] and the appearance of 
adaptive micellar membrane defects.[17] 
Figure 2.  Cytosolic protein delivery exemplified by Sav 9, with non-covalent 
DiSeL tag 8, fluorescent probes 11, F-actin ligands 13 and controls.  (A) In-scale 
molecular models of Sav[6] and DiSeL tag 8.  (B-D) CLSM images of HeLa Kyoto 
(B, C) and mouse myoblast C2C12 cells (D) incubated with (B) 12, (C) 10 and 
(D) 17 (all 2.5 µM).  Scale bar:  10 µm. 
The biotinylated DiSeL tag 8 was synthesized[18] for general non-
covalent connection to the substrate through the tetravalent 
streptavidin (Sav) 9, a ~60 kDa protein (Figure 2).[5,6,19]  
Complexes 10 were prepared by mixing Sav 9 with biotinylated 
fluorophores 11 and biotinylated DiSeL tag 8 in a 3:1 ratio.  All 
complex stoichiometries given in the following refer to mixing 
ratios, real existing product mixtures are naturally more 
complex.[5,6,19]  The complexes 10 were efficiently taken up into 
HeLa Kyoto cells (Figure 2C), while control complexes 12 without 
DiSeL tag 8 were inactive (Figure 2B).  Analogous complexes 
prepared with biotinylated AspA and ETP tags gave clearly 
weaker uptake efficiency (Figures S1, S2).  Cellular uptake of 
complex 10 was observed in all tested, overall four other cell lines 
(Figures 2, S3). 
Biotinylated phalloidin 13 was selected next as a functional 
substrate to be delivered in the cytosol.  Phalloidin is a toxic 
bicyclic heptapeptide from death cap mushrooms that specifically 
binds to and prevents the depolymerization of actin fibers.[20]  To 
facilitate the formation of trifunctional Sav conjugates with the 
targeting unit 13, transport unit 8 and the fluorescent reporter, Sav 
9 was covalently modified by tetramethyl rhodamine (TAMRA) 
fluorophores.  The biotin binding sites were protected first with the 
weakly bound 2-iminobiotin 14[21] to give complex 15, which in turn 
was reacted with the NHS-activated TAMRA 16.[18]  The resulting 
red-fluorescent Sav was then loaded with the DiSeL tag 8 and 
phalloidin 13 in a 3:1 ratio.  Added to mouse myoblast C2Cl2 cells, 
the resulting complex 17 efficiently tracked actin fibers, thus 
demonstrating DiSeL-driven delivery of functional proteins to the 
cytosol with high efficiency (Figures 2D, S6).  
 
Figure 3.  CLSM images of HeLa Kyoto cells incubated first with (A) 22, (B) 23 
and (C) 24 (all 2.5 µM), then with substrate 21 (10 µM).  (D) Relative 
fluorescence intensities of cells treated with 23 and 24 (2.5: open, 5.0: grey or 
10 µM black bars; note, the concentrations of Ru catalysts are double in 24) 
composed of WT Sav, K121R or S112Y-K121R mutants.  (E) Kinetics of the 
fluorescent product 18 formation in solution catalyzed by 23 (10 µM) containing 
WT Sav (open circles), K121R (filled circles) or S112Y-K121R mutants (filled 
diamonds). 
In recent years, there has been an increasing effort to exploitthe cell as a test-tube to complement the biochemical reactionnetworks with abiotic reactions1, 2 (Fig. 1a). With this goal in
mind, both organometallic complexes and nanoparticles have
been shown to catalyze abiotic reactions in Escherichia coli3–7,
mammalian cells8–21, and animals22–25. The outcome of such
intracellular abiotic reactions has been mostly limited to a
bioorthogonal output (i.e. uncaging of a fluorescent molecule or
labeling of a protein) or a loss-of-function (i.e. drug-release that
leads to cell death)3–25. In a limited number of cases however, a
gain-of-function (productive modulation/activation of cellular
function) by an intracellular abiotic reaction has been
reported26, 27.
In addition to these efforts, metabolic engineering in E. coli,
yeast, and higher organisms has received increasing attention
thanks to its enormous potential to produce either high-added
value products and biofuels or to cure diseases28. In this latter
context, the assembly of gene switches allows for the construction
of engineered mammalian cells that are capable of sensing the
extracellular environment and producing output molecules on
demand (Fig. 1b)29–31. Thus far, only genetically encodable
modules have been integrated into designer mammalian cells.
This limits the available intracellular reaction repertoire to those
accessible from engineered natural enzymes.
Artificial metalloenzymes (ArMs hereafter), which result from
incorporation of an organometallic moiety within a protein
scaffold, combine attractive features of both homogeneous- and
enzymatic catalysts (Fig. 1c and Fig. 2)32, 33. Most recently, the
groups of Tezcan34 and Ward6 have demonstrated the possibility
to assemble and use ArMs in vivo in the periplasm of E. coli. As a
next step, we aim to integrate an ArM in a designed mammalian
cell to upregulate the expression of a reporter protein via a
complex reaction cascade (Fig. 1c). To achieve this goal, the
following challenges need to be addressed: (i) the efficient uptake
of an ArM into mammalian cells; (ii) the assembly of a gene
switch that senses and responds to the product of the ArM
resulting in (iii) the intracellular upregulation of the gene switch
by the ArM.
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probe or a drug). b A designer mammalian cell engineered with a synthetic gene circuit responds to an external trigger molecule B. c Introduction of ArMs
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The catalysis of bioorthogonal transformations by artificial 
metalloenzymes for metabolic engineering in designer cells is a 
topic of current concern that relies on efficient cytosolic delivery.[6]  
We considered next the uncaging of fluorescent rhodamine 110 
(18)[22] by the “deallocase” 19, i.e., a Sav equipped with ruthenium 
complex 20 to catalyze the cleavage of Alloc groups in caged 21, 
to further elaborate on scope and limitations of DiSeL-mediated 
uptake (Figure 3). 
Although the hydrophobic and non-fluorescent substrate 21 is 
known to spontaneously diffuse into cells, its addition after 
deallocase 22 did not result in the appearance of fluorescence in 
HeLa Kyoto cells from the product 18 or the probe in 22 (Figures 
3A, S8).  These results suggest that the proteins failed to 
penetrate the cells.  In clear contrast, the addition of the doubly 
DiSeLated but non-fluorescent deallocase 23 generated 
increasing emission from HeLa Kyoto cells with increasing 
concentration, demonstrating the bioorthogonal uncaging of 21 by 
the cell-penetrating metalloenzyme 23 (Figures 3B, S9).  The 
deallocase showed efficient catalytic activity in all tested cell lines 
(Figure S10).  Confirming the central importance of delivery for 
bioorthogonal catalysis within cells, the metalloenzyme 24 with 
higher stoichiometry of catalytic unit and lower stoichiometry of 
transporter unit showed lower activity (Figures 3C, 3D, S9, S11, 
Tables S1, S2).  Further demonstrating the dominant contribution 
of cellular uptake, fluorophore uncaging in cells did not 
significantly depend on K121R and S112Y-K121R mutations[6] of 
Sav (Figure 3D, Tables S1, S2), despite their different catalytic 
activities in solution (Figures 3E, S12-S14).  According to the MTT 
assay, none of the tested DiSeLated metalloenzymes were toxic 
at 2.5 µM (Figure S15).  While the intracellular location of 
metalloenzymes could not be determined due to its invisibility, 
product 18 co-localized well with trackers of endosomes (PCC = 
0.64 ± 0.03) and mitochondria (PCC = 0.66 ± 0.04, Figure S16).  
Based on the similar localizations found previously with 18,[22,23] 
we speculate that the product formed in the cytosol freely diffuses 
to the organelles that have a natural propensity to accumulate it. 
 
Figure 4.  (A) Confocal images of live drosophila S2 cells treated with 6.66 nM 
DiSeL-QD complex 25 (80:1 molar ratio).  Left panel: Single confocal plane.  
Middle panel:  Time projection of a movie captured from the cell shown on the 
left.  Right panel:  Time projection color-coded according to frame number (n = 
500 frames, blue to violet, 5 μm scale bar).  (B) Quantitative analysis of short-
range QD tracks. Light blue area:  Weighted mean square displacement as a 
function of delay time (n = 6299 tracks).  Dashed dark blue line:  Fit of sub-
diffusion model MSD(t) = 4Dtα (R = 0.998; D = 0.150 ± 0.001 μm2/s, α = 0.627 ± 
0.016; 95% confidence interval). 
The delivery of large nanoparticles is promising for therapeutic 
purposes, but suffers from poor and not improving yields.[24]  The 
efficient cytosolic delivery of quantum dots (QDs) is considered 
particularly challenging, achieved usually by physical 
(electroporation, microinjection) but rarely by chemical methods, 
except with CPDs.[5]  However, DiSeL-QD complex 25, obtained 
by the addition of ~80 equivalents of DiSeL tag 8 to Sav-QDs, 
readily entered into the cytosol of insect cells (Figure 4A).  DiSeL-
mediated uptake delivered 57 ± 6 QDs (mean ± SEM, n = 20 cells) 
which was comparable to results with CPDs.[5]  Compared to 
CPDs, higher ratios of DiSeL tag 8 were used, but the conjugates 
precipitated less.  The motilities of thousands of QDs were 
categorized in three types by automatic tracking (Figure 4B):  1) 
short-range motion (79% of n = 8019 tracks over n = 13 cells), 2) 
long-range motion (6 tracks only) and 3) immobility.  The Mean 
Square Displacement (MSD) analysis of the QDs in short-range 
motion gave a diffusion coefficient D = 0.150 ± 0.001 μm2 s–1 (R 
= 0.998; α = 0.627 ± 0.016; 95% confidence interval).  Such 
subdiffusion with a confined motility behavior is characteristic for 
QDs delivered in the cytosol.[5,25]  These results thus suggested 
that DiSeL mediates the delivery of QDs to the cytosol with 79% 
efficiency with little endosomal capture (0.06%) and, compared to 
CPDs reduced precipitation and immobilization on the cell surface 
(20% in total). 
Figure 5.  A working hypothesis for the mode of action of DiSeL-mediated 
uptake, focusing on dynamic covalent dichalcogenide exchange cascades to 
walk along disulfide tracks in a membrane protein (right, grey), with a large 
substrate (purple circle) carried moving through an adaptive micellar membrane 
defect (left). 
Concerning the mode of action, the diversity of delivered 
substrates makes trivial changes in physical properties, such as 
increased hydrophobicity to favorize passive diffusion, unlikely to 
account for DiSeL-mediated uptake.  Insensitivity to standard 
inhibitors and negligible endosomal capture disfavors uptake by 
different forms of endocytosis.[11]  A tentative mode of action 
considers that rapid opening of the diselenolane with an exofacial 
thiol produces a selenolate that remains deprotonated even under 
slightly acidic conditions (Figure 5).  Exchange of this reactive 
selenolate initiates a molecular walk[15] along disulfide tracks 
across the membrane, causing temporary protein denaturation[16] 
on one side and the temporary appearance of adaptive, non-leaky 
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and self-healing micellar defects[17] on the other side, thus 
assuring compatibility with the translocation of substrates of 
variable, even very large size (Figure 5).  Release into the cytosol 
is conceivable by favorable ring closure[11] or by exchange with 
glutathione.[1,2]  Needed for continuing transport (and function), 
the initial redox state of the membrane protein can be readily 
restored by reverse thiol/disulfide exchange cascades.  This 
working hypothesis is compatible with extensive model studies, 
including poor retention on thiol-affinity columns[11] and trapping 
of reactive intermediates.[26]  A striking similarity with the repair of 
misfolded protein with diselenides further supports the walker 
hypothesis because this catalytic process has been studied in 
detail and shown to occur also in vivo.[16]   
However, independent of the mode of action, the superb substrate 
scope identified in this study together with the small size, synthetic 
accessibility, stability, solubility, low toxicity and high efficiency 
promise that diselenolane-mediated cellular uptake could become 
quite useful in practice.  Particularly interesting is the efficient 
cytosolic delivery of two orders of magnitude larger substrates like 
protein-coated quantum dots (diameter ~15 nm) by the miniscule 
diselenolanes (diameter ~0.3 nm), a stunning disproportion that 
is reminiscent of the ant carrying the elephant. 
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